This inventor holds 3 USPTO granted patents. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1977-1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977-1978
Title: Yasuhiro Hosokawa: Innovator in Anti-Ulcerous Compounds
Introduction
Yasuhiro Hosokawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-ulcerous compounds. With a total of 3 patents to his name, his work has the potential to impact the treatment of ulcer-related conditions.
Latest Patents
Hosokawa's latest patents include innovative compounds that exhibit anti-ulcerous action. One of his patents focuses on anti-ulcerous tyrosine derivatives, which are characterized by specific chemical formulas. These compounds include variations where R₁ is phenyl or cycloalkyl, and R₂ can be hydrogen or lower alkyl. Another patent details the process for preparing tyrosine derivatives with similar structural characteristics, emphasizing their therapeutic potential.
Career Highlights
Yasuhiro Hosokawa is associated with Daiichi Seiyaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. His work at the company has allowed him to explore and develop new medicinal compounds that address critical health issues.
Collaborations
Throughout his career, Hosokawa has collaborated with esteemed colleagues such as Tosaku Miki and Tamotsu Miwa. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Yasuhiro Hosokawa's contributions to the field of medicinal chemistry, particularly in anti-ulcerous compounds, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile